MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma - Wikidata - awgldk - TriplyDB

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

http://www.wikidata.org/entity/Q36546760

about

microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges The challenge of developmental therapeutics for adrenocortical carcinoma Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk Network analysis reveals potential markers for pediatric adrenocortical carcinoma Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway.Noncoding RNAs Regulating Cancer Signaling Network.Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.Emerging Role of MicroRNAs in mTOR Signaling.miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.Response to "An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)".

P2860

Q26772746-007991E3-B915-43B7-8CD0-37EB9137E98E Q28072970-FC557187-4E83-4F26-82AF-24A520A5B76B Q33650304-ABC9F148-7C2C-4F8C-83D5-AAC6CBC66EDF Q36992190-753AD088-7C0F-4C10-932D-D5342EDE4B12 Q37001437-8F23606A-6B9F-4FF5-856B-C95EC624E5AB Q37143014-58C1215E-E54B-48A1-B91F-B7B498E319C0 Q37208190-7B0DA9C4-9347-4D53-9839-D767A4F465C8 Q37327593-ED2C995C-D87D-4F89-B7E0-E576E4AD76F8 Q37718177-33C48376-D369-4A0F-8995-B5E5282EC7A3 Q38885498-E1155540-7991-42F5-9173-F832E350AA2F Q38973406-CD0A1925-8606-44E7-AE99-860791127238 Q39151248-CEFC416E-A28E-4619-A378-0215EEBB1D4C Q46556476-995C2EDB-AB14-4432-88DD-0AD814BCCA0F Q47107902-B58019FF-E5F0-46A0-8DBD-CC3D12839050 Q49676347-9C87E665-D496-430F-82C0-39D8F80B3FB7 Q52659186-EA2ACE91-9361-438C-A677-CE00EC985558

P2860

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

http://www.wikidata.org/entity/Q36546760

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@ast

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@en

type

label

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@ast

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@en

prefLabel

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@ast

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@en

P1433

Q36546760-1137B210-57D6-4EA1-9601-37ACA20D59F9

P1476

Q36546760-44DDDF1A-58D9-40CD-913B-6C97454AC626

P2093

Q36546760-0844D70C-2E0D-40FC-B14F-4EC6B3D5A6DF

Q36546760-2434F70E-E46A-471A-B9D1-90A9501FD4F7

Q36546760-5A2468E2-859F-4C3C-BA87-F6A755B0FC5F

Q36546760-76A859B6-054D-4187-B5B3-50BB60E6C2E2

Q36546760-9FE7BB71-552D-4F78-9EC0-F3DC4FF02B7A

Q36546760-A6BCC1CD-A0B3-4831-A3E8-EF6DC009256D

Q36546760-A7018740-98D2-42E1-B434-611A0F7940DA

Q36546760-A982CB8B-7A42-40BE-8E59-B6A9624BAAC3

Q36546760-C20858B6-9289-4CD8-A71B-C14496A8C157

Q36546760-D974060E-A765-43BE-86D7-FF48A55F557B

P2860

Q36546760-021647CF-4517-4A0E-A799-B34A794A4189

Q36546760-02E2CB51-C13D-487E-8E88-05EE1D8C8B65

Q36546760-06D8E013-BE31-48A6-8478-1B239A99F67B

Q36546760-07A7B944-8A05-4F0A-9187-DAEB006C5D39

Q36546760-087D5C0B-871A-41C4-95E1-F104A5872D33

Q36546760-09802E75-1BBD-4EFB-8A63-0E6C38E6DD0A

Q36546760-09FE79A0-D113-47BF-A67C-6E5DCFA6C8B9

Q36546760-12EBA806-64E2-4D76-A949-F34CC0D4BCDD

Q36546760-1E71B7D7-779A-44C3-8FB7-5AE9499A1E13

Q36546760-20460EB6-98A9-409E-9874-2E0B2E5E30BF

P304

Q36546760-52559C50-B34B-4ACE-9AE3-4BFCF0C1A8C0

P31

Q36546760-5EE900C6-9FF5-4572-B30C-4C92FCC879D4

P356

Q36546760-6AA6D0E8-6A02-4F1F-8DB2-4387A587A50B

P407

Q36546760-5FCF8C2F-6B43-4E0C-AA88-67D735E9FF29

P433

Q36546760-1ADE07E7-1E0D-4665-8976-EB829F6D189B

P478

Q36546760-F23A78AC-1AC0-4744-9712-C93BC709A175

P50

Q36546760-C77101C4-0501-454C-AD48-49905BD50025

Q36546760-D1FDCD65-92E5-4E25-82EC-36C200358144

P577

Q36546760-903BF03C-3EBE-409B-8F35-2052FD5FBB44

P5875

Q36546760-2A48CA20-5F87-4226-A322-8D6511EFE3E0

P698

Q36546760-F3184C24-6269-43D5-8766-6266E4CC31DC

P921

Q36546760-D02F8C61-F30F-4270-B456-8D71C2113884

P932

Q36546760-5E6C52C8-22D7-4992-BE84-B6E58BBAA917

P356

ONCOTARGET.5383

P1433

P1476

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma

@en

P2093

Alex L Feeney

http://www.w3.org/2001/XMLSchema#string

Anthony J Gill

http://www.w3.org/2001/XMLSchema#string

Bruce G Robinson

http://www.w3.org/2001/XMLSchema#string

Edward Kim

http://www.w3.org/2001/XMLSchema#string

Himanshu Brahmbhatt

http://www.w3.org/2001/XMLSchema#string

Jennifer A MacDiarmid

http://www.w3.org/2001/XMLSchema#string

Jing Ting Zhao

http://www.w3.org/2001/XMLSchema#string

Jocelyn Weiss

http://www.w3.org/2001/XMLSchema#string

Julian C Ip

http://www.w3.org/2001/XMLSchema#string

Nancy Mugridge

http://www.w3.org/2001/XMLSchema#string

P2860

The rise of regulatory RNA

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Patient-derived tumor xenografts: transforming clinical samples into mouse models

The let-7 microRNA represses cell proliferation pathways in human cells

Causes and consequences of microRNA dysregulation in cancer

microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma.

Small RNA combination therapy for lung cancer

P304

36675-36688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5383

http://www.w3.org/2001/XMLSchema#string

P407

P433

34

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Anthony R Glover

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282583836

http://www.w3.org/2001/XMLSchema#string

P698

26452132

http://www.w3.org/2001/XMLSchema#string

P921

P932

4742203

http://www.w3.org/2001/XMLSchema#string